Poland and Slovenia included in US-EU mutual recognition agreement

04:52 EST 20 Feb 2019 | Pharmafile

Poland and Slovenia have been deemed capable of carrying out Good Manufacturing Practice (GMP) inspections at an equivalent level to the United States.

With the addition of Poland and Slovenia, 22 countries in the European Union (EU) are now approved to carry out GMP inspections.

The agreement between the EU and the US allows partners to recognise the inspections carried out by other recognised countries.

The partnership is aimed at reducing the regulatory burden associated with duplicating GMP inspections.

read more

Original Article: Poland and Slovenia included in US-EU mutual recognition agreement


More From BioPortfolio on "Poland and Slovenia included in US-EU mutual recognition agreement"

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...